Gene Query: CYB5R2

Dataset Description Geneva Score
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 50.69
RNAseq of IL-36 stimulated primary human keratinocytes 43.2
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 40.94
Comparing gene expression in iPSC derived RPE from control and AMD donors 28.83
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 27.35
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 26.3
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 25.35
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 25.35
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 22.08
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 22.08
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 21.18
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 20.97
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 19.93
MeRIP-seq for heat shock in B-cell lymphoma cells 18.38
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 17.43
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 15.49
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 14.9
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 14.9
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 14.61
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 14.05
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 12.78
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 12.11
The Human Testis Cell Atlas via Single-cell RNA-seq 12.01
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 11.59
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 11.44
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 11.44
RNAseq Analysis in glioblastoma cells treated with Mepazine 10.93
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 10.67
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 10.39
The conserved transcriptional landscapes in human spermatogenesis 10.28
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 9.96
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.73
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.73
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.57
IRF2 is a master regulator of human keratinocyte stem cell fate 9.57
RNA-seq of IL-4 stimulated human keratinocytes 9.38
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 8.89
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 8.68
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 8.64
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 8.54
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.36
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.36
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 8.26
RNA-seq of human fibroblasts after irradiation 8.03
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 8.0
Expression charcaterization of an internal protocol developed to differentiate RPE cells 7.6
Altering cancer transcriptomes using epigenomic inhibitors 7.58
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 7.58
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 6.89
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 6.74
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.6
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 6.47
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 6.4
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.37
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 6.29
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 6.24
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.22
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.22
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.22
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 6.2
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 5.94
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 5.81
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.75
Universal alternative splicing of noncoding exons 5.68
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.66
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.66
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.62
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 5.58
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 5.53
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 5.53
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 5.46
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 5.34
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.26
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.26
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.2
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 4.95
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 4.95
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.89
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.81
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.73
Transcriptional effect of ETV1 knockdown in melanoma cells 4.7
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.7
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.48
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 4.34
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 4.31
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 4.31
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.3
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 4.19
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 4.13
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 4.12
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.11
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.11
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.11
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.09
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.93
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 3.89
TCF7L1 knockdown in pancreatic cancer 3.84
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 3.81
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.72
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.64
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.63
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.62
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 3.55
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.54
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 3.46
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.46
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 3.42
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 3.41
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.39
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.38
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.38
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.37
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.37
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.37
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.29
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.29
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.28
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.28
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 3.28
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.28
Differential gene expression of human melanoma cells [RNA-seq] 3.28
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.24
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 3.23
Examining serotonergic neuron differentiation from human iPSCs 3.22
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.19
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.18
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.18
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 3.16
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.15
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 3.11
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 3.1
AR-independent prostate cancer is sustained through FGF signaling 3.09
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 3.08
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.02
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 2.97
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 2.94
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.91
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.88
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.86
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.85
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.85
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 2.85
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.76
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.73
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.72
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.66
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 2.65
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 2.65
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.63
Identification of differentially expressed genes between senescence and senescence bypass cells 2.57
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.55
Multiple sclerosis and EAE 2.54
Human optic chiasm from healthy controls and multiple sclerosis patients 2.54
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 2.51
Transcriptomic and gene ontology profiling of the human corneal cell types 2.51
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 2.48
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 2.45
RNA polymerase in pre-B-ALL cell lines 2.44
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.43
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.43
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.39
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.39
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.39
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.39
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 2.38
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.38
DIGIT regulates endoderm differentiation of human embryonic stem cells 2.37
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 2.34
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 2.3
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.29
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.26
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.26
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.17
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 2.17
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.17
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 2.15
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 2.15
Effect of Hotair overexpression in human breast cancer cell lines 2.15
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.14
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.1
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.09
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.08
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.08
Transcriptome analysis of H9 hESC derived cerebral organoids 2.07
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.07
IL-33 activates tumor stroma to promote intestinal polyposis 2.07
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 2.05
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 2.04
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.03
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.03
RNA-seq analysis of RALD iPSCs after in vitro differentiation 2.02
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.0
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 2.0
RNA-seq of naive and primed ES cells (NHSM) 1.99
RNA splicing alteration on glioblastoma and normal neural stem cells 1.99
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 1.98
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 1.98
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.98
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.97
RNA expression following TMPRSS11B overexpression or depletion 1.97
A sister of NANOG regulates genes expressed in pre-implantation human development 1.95
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 1.93
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 1.92
In vitro modeling of human germ cell development using pluripotent stem cells 1.91
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 1.91
Ro60-knockout cells 1.9
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.89
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 1.89
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.88
Nonpregnant and term pregnant human myometrial tissues 1.88
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 1.88
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 1.87
Total RNA sequencing of WT intestinal orgaonids. 1.87
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 1.86
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.85
The human blood-nerve barrier transcriptome 1.82
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 1.82
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 1.82
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 1.82
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.81
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.8
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 1.8
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 1.79
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.77
CD73 knockdown effect in pancreatic cancer cell lines 1.77
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 1.74
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 1.74
Metabolism as an early predictor of DPSCs aging 1.72
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.72
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.72
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.72
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.7
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.67
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 1.66
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 1.66
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.66
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.66
BAF controls genome accessibility 1.64
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 1.63
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.63
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 1.62
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 1.61
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 1.59
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.58
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.57
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 1.56
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 1.56
Global epigenomic reconfiguration during mammalian brain development 1.54
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.53
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.53
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 1.53
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 1.52
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 1.52
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.51
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.5
Differentially expressed vascular development genes for iPSC-ECs from CDI 1.49
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.49
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 1.49
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.49
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.49
SRSF2 mutations impair hematopoiesis and alter exon recognition 1.48
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.47
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.46
p63 controls the enhancer landscape during keratinocyte differentiation 1.44
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 1.44
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.43
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.43
MHC Transcriptomic landscape at haplotype-specific resolution 1.41
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.41
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.4
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.39
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.37
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.37
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.36
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 1.36
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.35
MCF10A H-Ras RNA-Seq 1.34
TGF-β regulation of miRNA expression in pancreatic cancer 1.33
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.32
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.32
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.32
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.32
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.31
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.31
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.31
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.31
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 1.3
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.3
Transcriptional responses of melanoma cells to BRAF inhibition 1.29
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 1.29
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.29
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.29
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 1.28
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 1.27
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 1.27
Regulation of Lipids is Central to Replicative Senescence 1.26
RNA-seq of shEZH2 cells 1.26
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 1.26
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.24
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.21
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.21
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 1.2
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.18
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.17
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.16
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.15
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.15
RNA sequencing analysis of human embryonic stem cells and axial progenitors 1.14
Overexpression and knockdown experiment for circCSNK1G3 1.11
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.11
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.11
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.09
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.09
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 1.09
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.07
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.06
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.06
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.06
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.06
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.06
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.05
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.04
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.04
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 1.03
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 1.02
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.01
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.01
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.0
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 1.0
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.0
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.0
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 0.99
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 0.99
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.99
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 0.98
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 0.97
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.97
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.97
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.96
Non-coding regions are the main source of tumor-specific antigens [human] 0.96
Non-coding regions are the main source of tumor-specific antigens 0.96
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.95
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.95
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.95
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.94
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.94
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.94
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.93
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 0.93
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.92
RNA-Seq of the corpus callosum from 12 individuals 0.91
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.91
Loss of endometrial plasticity in recurrent pregnancy loss 0.91
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.89
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.86
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.86
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.85
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 0.84
ML29755 RNA-seq data 0.83
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.8
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.8
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.79
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.79
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 0.78
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.78
Cerebellar differentiation in Ataxia-Telangiectasia 0.76
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.76
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.75
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.74
Role of COP1 on MAP kinase transcriptional output in melanoma 0.74
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 0.74
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.73
RNAseq analysis of ruxolitinib treated breast cancers 0.73
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.73
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.71
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.71
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.71
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.71
Transcriptome analysis of human lung epithelial cells 0.7
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 0.7
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.7
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.7
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.68
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.67
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.67
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.66
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.64
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.63
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.62
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.62
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.61
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.61
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.6
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 0.59
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.57
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.57
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.57
Polarized B -cell functions 0.56
The Genetic Landscape of Diamond-Blackfan Anemia 0.55
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.55
Gene expression changes in human melanoma cell lines compared to primary melanocytes 0.55
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.55
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.54
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.54
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.53
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.53
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.53
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.53
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.52
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.5
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.5
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.47
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.47
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.45
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.45
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.42
iPSC-Derived Cholangiocytes 0.41
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.4
Changes in human endometrial gland transcriptome over the window of implantation 0.4
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.4
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 0.39
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.37
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.37
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.35
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.35
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.33
Transcriptomic analysis of frontal fibrosing alopecia 0.33
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.32
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.32
CUREfast: Accelerating research with families 0.32
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.32
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.32
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.31
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.3
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.3
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.29
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.29
Gene expression of thyroid cancer cell lines 0.29
Derivation and differentiation of haploid human embryonic stem cells 0.29
Patient-derived xenograft platform for metastatic melanoma 0.28
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.25
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.25
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.25
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.24
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.23
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.23
RNA-seq of tumor cells following angiopellosis extravasation 0.23
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.22
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.22
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.21
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.21
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.2
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.19
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 0.19
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.18
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.17
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.17
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.17
Gene expression analysis of breast cancer cell-lines 0.16
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.16
Identification of the role of polydom in neurofibromas 0.16
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.16
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.16
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.15
RNA-seq in endometrial stromal tumors 0.15
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.14
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.14
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.14
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.14
SOX11 knockdown in B-ALL cell lines 0.13
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.12
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.12
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.1
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.09
Preclinical model of obesity and ER-positive breast cancer 0.09
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.08
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.08
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.08
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.08
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.07
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.07
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.07
RNAseq of Breast cancer PDX samples 0.07
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.06
Identification of a LIF-responsive replication-competent human β cell 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.05
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.04
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.03
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.03
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.02
RNA-seq data 0.02
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.02
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.02
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.0
Clinker: visualizing fusion genes detected in RNA-seq data 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation